News

Shire said that the lawsuit results from abbreviated new drug applications (ANDAs) filed by Impax and Watson for generic versions of 4mg guanfacine hydrochloride extended release tablets, INTUNIV,

MOR208 (XmAb5574) is a potent monoclonal anti-CD19 antibody to which MorphoSys recently gained worldwide access via an exclusive license and collaboration agreement with Xencor. MorphoSys and Xencor said

The open label, multi-centre, randomised Phase 2 study will evaluate the efficacy and safety of treatment with imetelstat plus paclitaxel (with or without bevacizumab) versus paclitaxel (with or

Microbix is transferring all of its influenza vaccine assets into Crucible, along with an exclusive worldwide license to its Virusmax technology, and the company’s 50% ownership interest in

During the conference – ‘Rare neurological diseases of childhood,’ the participants endorsed a ‘Declaration of Principles’ launching a new initiative to increase research into rare neurological diseases and

The collaboration combines GE Healthcare’s global presence and expertise in biopharmaceutical manufacturing technology with G-Con’s modular portable flexible clean-room technology. The collaboration will offer comprehensive GMP manufacturing solutions

APR said Zolmitriptan ODF is a very thin polymeric film strip with a size of 3sqcm and 6sqcm for the 2,5mg and 5mg dosage strengths, respectively. Zolmitriptan ODF

The compound targets AD via selective butyrylcholinesterase inhibition (BChEI) as well as with a disease modifying activity via amyloid precursor protein (APP) inhibition. QR Pharma has completed all

Using A5 Labs production technology, it is anticipated that approximately 2,000 doses of the VI-1718 will be manufactured with certificates of analysis in the next 4 weeks. A5